- Home
- SQFT vs AIMD Comparison
SQFT vs AIMD Comparison
Compare SQFT & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- AIMD
- Stock Information
- Founded
- SQFT 1999
- AIMD 1984
- Country
- SQFT United States
- AIMD United States
- Employees
- SQFT N/A
- AIMD N/A
- Industry
- SQFT Real Estate Investment Trusts
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- AIMD Health Care
- Exchange
- SQFT Nasdaq
- AIMD Nasdaq
- Market Cap
- SQFT 8.1M
- AIMD 8.5M
- IPO Year
- SQFT 2020
- AIMD N/A
- Fundamental
- Price
- SQFT $0.67
- AIMD $0.62
- Analyst Decision
- SQFT
- AIMD
- Analyst Count
- SQFT 0
- AIMD 0
- Target Price
- SQFT N/A
- AIMD N/A
- AVG Volume (30 Days)
- SQFT 27.0K
- AIMD 227.7K
- Earning Date
- SQFT 03-04-2025
- AIMD 03-07-2025
- Dividend Yield
- SQFT N/A
- AIMD N/A
- EPS Growth
- SQFT N/A
- AIMD N/A
- EPS
- SQFT N/A
- AIMD N/A
- Revenue
- SQFT $18,586,052.00
- AIMD $40,633.00
- Revenue This Year
- SQFT N/A
- AIMD N/A
- Revenue Next Year
- SQFT N/A
- AIMD N/A
- P/E Ratio
- SQFT N/A
- AIMD N/A
- Revenue Growth
- SQFT 5.44
- AIMD N/A
- 52 Week Low
- SQFT $0.47
- AIMD $0.40
- 52 Week High
- SQFT $1.39
- AIMD $3.10
- Technical
- Relative Strength Index (RSI)
- SQFT 49.72
- AIMD 47.20
- Support Level
- SQFT $0.62
- AIMD $0.56
- Resistance Level
- SQFT $0.73
- AIMD $0.77
- Average True Range (ATR)
- SQFT 0.05
- AIMD 0.06
- MACD
- SQFT 0.01
- AIMD -0.01
- Stochastic Oscillator
- SQFT 69.23
- AIMD 28.67
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.